|
Volumn 66, Issue 24, 2009, Pages 2162-2163
|
Emergency-use authorization of peramivir
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
CYCLOPENTANE DERIVATIVE;
GUANIDINE DERIVATIVE;
NEW DRUG;
PERAMIVIR;
ADULT;
CHILD;
EMERGENCY HEALTH SERVICE;
HUMAN;
INFLUENZA;
INFLUENZA VIRUS A H1N1;
INTENSIVE CARE;
LETTER;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PUBLIC HEALTH SERVICE;
UNITED STATES;
ADULT;
ANTIVIRAL AGENTS;
CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.);
CHILD;
CLINICAL TRIALS, PHASE II AS TOPIC;
CLINICAL TRIALS, PHASE III AS TOPIC;
CRITICAL CARE;
CYCLOPENTANES;
DRUGS, INVESTIGATIONAL;
EMERGENCY MEDICAL SERVICES;
GUANIDINES;
HUMANS;
INFLUENZA A VIRUS, H1N1 SUBTYPE;
INFLUENZA, HUMAN;
UNITED STATES;
|
EID: 77449146427
PISSN: 10792082
EISSN: 15352900
Source Type: Journal
DOI: 10.2146/ajhp090584 Document Type: Letter |
Times cited : (7)
|
References (7)
|